199 related articles for article (PubMed ID: 36685552)
1. Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.
Mestre-Durán C; Martín-Cortázar C; García-Solís B; Pernas A; Pertíñez L; Galán V; Sisinni L; Clares-Villa L; Navarro-Zapata A; Al-Akioui K; Escudero A; Ferreras C; Pérez-Martínez A
Front Immunol; 2022; 13():1045316. PubMed ID: 36685552
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory receptor CD47 binding to plasma TSP1 suppresses NK-cell IFN-γ production via activating the JAK/STAT3 pathway during HIV infection.
Lang B; Wang M; Zhang Z; Fu Y; Han X; Hu Q; Ding H; Shang H; Jiang Y
J Transl Med; 2023 Nov; 21(1):869. PubMed ID: 38037074
[TBL] [Abstract][Full Text] [Related]
4. Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628).
von Bubnoff N; Ihorst G; Grishina O; Röthling N; Bertz H; Duyster J; Finke J; Zeiser R
BMC Cancer; 2018 Nov; 18(1):1132. PubMed ID: 30453910
[TBL] [Abstract][Full Text] [Related]
5. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
Arsenault RJ; Kogut MH; He H
Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
[TBL] [Abstract][Full Text] [Related]
6. JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation.
Gotthardt D; Trifinopoulos J; Sexl V; Putz EM
Front Immunol; 2019; 10():2590. PubMed ID: 31781102
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation.
Hu X; Chen J; Wang L; Ivashkiv LB
J Leukoc Biol; 2007 Aug; 82(2):237-43. PubMed ID: 17502339
[TBL] [Abstract][Full Text] [Related]
8. JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions.
Beckman JD; DaSilva A; Aronovich E; Nguyen A; Nguyen J; Hargis G; Reynolds D; Vercellotti GM; Betts B; Wood DK
J Thromb Haemost; 2023 May; 21(5):1366-1380. PubMed ID: 36738826
[TBL] [Abstract][Full Text] [Related]
9. Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells.
Terrén I; Mikelez I; Odriozola I; Gredilla A; González J; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
Front Immunol; 2018; 9():737. PubMed ID: 29713323
[TBL] [Abstract][Full Text] [Related]
10. Impact of JAK/STAT inhibitors on human monocyte-derived-macrophages stimulated by cigarette smoke extract and lipopolysaccharide.
Verres Y; da Silva CO; Aljebawi B; Bodin A; Barreto E; Lagente V; Victoni T
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1187-1196. PubMed ID: 35876719
[TBL] [Abstract][Full Text] [Related]
11. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Vargas-Hernández A; Mace EM; Zimmerman O; Zerbe CS; Freeman AF; Rosenzweig S; Leiding JW; Torgerson T; Altman MC; Schussler E; Cunningham-Rundles C; Chinn IK; Carisey AF; Hanson IC; Rider NL; Holland SM; Orange JS; Forbes LR
J Allergy Clin Immunol; 2018 Jun; 141(6):2142-2155.e5. PubMed ID: 29111217
[TBL] [Abstract][Full Text] [Related]
12. Repression of interferon β-regulated cytokines by the JAK1/2 inhibitor ruxolitinib in inflammatory human macrophages.
Febvre-James M; Lecureur V; Augagneur Y; Mayati A; Fardel O
Int Immunopharmacol; 2018 Jan; 54():354-365. PubMed ID: 29202299
[TBL] [Abstract][Full Text] [Related]
13. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors.
Nishiya T; DeFranco AL
J Biol Chem; 2004 Apr; 279(18):19008-17. PubMed ID: 14976215
[TBL] [Abstract][Full Text] [Related]
14. New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.
Marcuzzi A; Rimondi E; Melloni E; Gonelli A; Grasso AG; Barbi E; Maximova N
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337171
[TBL] [Abstract][Full Text] [Related]
15. Activated Natural Killer Cell Promotes Nonalcoholic Steatohepatitis Through Mediating JAK/STAT Pathway.
Wang F; Zhang X; Liu W; Zhou Y; Wei W; Liu D; Wong CC; Sung JJY; Yu J
Cell Mol Gastroenterol Hepatol; 2022; 13(1):257-274. PubMed ID: 34506952
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
17. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity.
Lauzon NM; Mian F; MacKenzie R; Ashkar AA
Cell Immunol; 2006 Jun; 241(2):102-12. PubMed ID: 17049504
[TBL] [Abstract][Full Text] [Related]
18. Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade.
Curran SA; Shyer JA; St Angelo ET; Talbot LR; Sharma S; Chung DJ; Heller G; Hsu KC; Betts BC; Young JW
Cancer Immunol Res; 2017 Jan; 5(1):52-60. PubMed ID: 27923824
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TLR4/MyD88/p38MAPK and JAK/STAT pathway in RAW 264.7 cells by Alpinia galanga reveals its beneficial effects in inflammation.
George G; Shyni GL; Abraham B; Nisha P; Raghu KG
J Ethnopharmacol; 2021 Jul; 275():114132. PubMed ID: 33887419
[TBL] [Abstract][Full Text] [Related]
20. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
